Marea Therapeutics Appoints Rebecca Juliano As Chief Development Officer and Max Zeiberg As Senior Vice President, Corporate Development
Marea Therapeutics Appoints Rebecca Juliano As Chief Development Officer and Max Zeiberg As Senior Vice President, Corporate Development
12/19/24, 6:06 PM
Location
san franciscoIndustry
therapeutics
biotechnology
Position
vice president of corporate development
chief development officer
Marea Therapeutics, Inc announced the addition of Rebecca Juliano, PhD, as Chief Development Officer, and Max Zeiberg as Senior Vice President, Corporate Development.
Company Info
Location
san francisco, california, united states
Additional Info
Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases. The company’s lead program, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. Marea is led by a dynamic team of scientists and company builders with deep know-how and experience in cardiometabolic diseases, human genetics and adipocyte biology.